J&J vaccine shows 66% efficacy for moderate and severe Covid-19
US pharmaceutical group says it will soon seek emergency authorisation for one-shot jab
Full Article
J&J vaccine shows 66% efficacy for moderate and severe Covid-19
FT.com
0 shares
1 views
You might like
Related news coverage
Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data
TechCrunch
Another COVID-19 vaccine is almost ready to begin being distributed – a single-shot inoculation made by Johnson & Johnson’s..